Physician profile
Corinne E Capurro
NPI 1811992910
$896.67
in general payments reported to CMS, 2019-2025
19 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $30.43 · 2021: $119 · 2022: $180 · 2023: $79.33 · 2024: $43.78 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $362.45 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $120.88 | 2024-2025 | Veozah |
| Allergan, INC. | $76.71 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.70 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $29.57 | 2023-2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $29.47 | 2019 | |
| Myovant Sciences INC. | $29.31 | 2022 | |
| Hologic Sales and Service, LLC | $28.02 | 2019 | |
| Daiichi Sankyo INC. | $21.33 | 2022 | |
| Pfizer INC. | $20.81 | 2019 | |
| Ethicon US, LLC | $18.64 | 2025 | Endopath Xcel |
| Glaxosmithkline, LLC. | $18.02 | 2019 | |
| Sumitomo Pharma America, INC. | $14.51 | 2024 | Myfembree |
| Roche Diagnostics Corporation | $13.72 | 2019 | |
| Minerva Surgical, INC | $13.54 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $13.40 | 2019 | |
| Baxter Healthcare | $12.95 | 2019 | |
| Boston Scientific Corporation | $12.90 | 2019 | |
| Mayne Pharma Commercial LLC | $9.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Capurro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.